Advertisement Cook Medical to introduce Stemulate human platelet lysate cell culture media supplement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cook Medical to introduce Stemulate human platelet lysate cell culture media supplement

Cook Medical will introduce its Stemulate pooled human platelet lysate cell culture media supplement at the 2014 International Society for Cellular Therapy meeting, 23 April to 26 April 2014.

Stemulate provides researchers and cell therapy companies a cell expansion alternative to fetal bovine serum. Stemulate supports the expansion of multiple types of cells in vitro, including endothelial colony forming cells, fibroblasts, and mesenchymal stem cells (MSCs) from a variety of tissue sources.

Brad King from the advanced lab products group at Cook Medical noted that the company knows that researchers and companies working in cell therapy are passionate about developing the best clinical product.

"To take their idea from the lab to the patient, they are constantly looking for ways to improve their manufacturing. Based on our experience and feedback from customers, we’re confident Stemulate offers them a safe and consistent cell culture media supplement," King added.

Stemulate is produced in batches larger than 20l and the supply of human donor platelets is reliable and consistent. This helps to stabilize the product’s availability and pricing.